News: Trius Therapeutics Inc (TSRX.W)
TSRX.W on CBOE When Trading NASDAQ Global Select Market
7.90USD
23 May 2013
7.90USD
23 May 2013
Price Change (% chg)
$0.31 (+4.08%)
$0.31 (+4.08%)
Prev Close
$7.59
$7.59
Open
$7.50
$7.50
Day's High
$7.90
$7.90
Day's Low
$7.41
$7.41
Volume
4,900
4,900
Avg. Vol
3,116
3,116
52-wk High
$8.40
$8.40
52-wk Low
$4.44
$4.44
Select another date:
Mon, Mar 25 2013
BRIEF-Trius Therapeutics up in premarket after tedizolid study results
NEW YORK, March 25 - Trius Therapeutics Inc : * Up 6.6 percent to $7.45 in premarket after tedizolid study results
Select another date:
- SmithOnStocks Opines On Stocks: May 19th Edition
- Trius Patent Intrigues Investors, And Perhaps Cubist Pharmaceuticals
- Trius Therapeutics: New, Positive Dimension For Investment Outlook
- Alimera Sciences And Trius Therapeutics: 2 Big Biotechs For 2013
- SmithOnStocks Opines On Recent Biotech News
- Cramer's Mad Money - 10 Things To Watch In The Week Ahead (5/3/13)
Press Releases
- Trius Therapeutics Completes Enrollment in Second Phase 3 Trial of Tedizolid for Skin and Skin Structure Infections
- Trius Therapeutics Ranked Number 42 Fastest Growing Company in North America on Deloitte's 2012 Technology Fast 500(TM)
- Trius to Present at November Investor Conferences
- Trius Therapeutics to Host Analyst and Investor Update Call
- Trius Therapeutics Reports 2012 Third Quarter Financial Results
- Tedizolid Safety Data Presented at IDWeek
- Trius Therapeutics to Present Data From Tedizolid Clinical Studies at IDWeek Conference
- Trius Therapeutics Reports Data on Broad-Spectrum Antibiotics at 52nd Annual ICAAC Meeting
- Trius Therapeutics Reports Data on Broad-Spectrum Antibiotics at 52nd Annual ICAAC Meeting
- Trius Therapeutics Announces Data Presentations on Tedizolid at 52nd Annual ICAAC Meeting
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
